Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein

References

1. Battegay M., Fikes J., Di Bisceglie A. M., Wentworth P. A., Sette A., Celis E., Ching W.-M., Grakoui A., Rice C. M., Kurokohchi K., Berzofsky J. A., Hoofnagle J. H., Feinstone S. M., Akatsuka T. 1995; Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. Journal of Virology 69:2462–2470
   [Google Scholar]
2. Braakman E., Rotteveel F. T. M., van Bleek G., van Seventer G. A., Lucas C. J. 1987; Are MHC class Il-restricted cytotoxic T lymphocytes important?. Immunology Today 8:265–267
   [Google Scholar]
3. Cerny A., McHutchinson J. G., Pasquinelli C., Brown M. E., Brothers M. A., Grabscheid B., Fowler P., Houghton M., Chisari F. V. 1995; Cytotoxic T lymphocyte response to hepatitis C-derived peptides containing the HLA A2.1 motif. Journal of Clinical Investigation 95:521–530
   [Google Scholar]
4. Chan S.-W., McOmish F., Holmes E. C., Dow B., Peutherer J. F., Follett E., Yap P. L., Simmonds P. 1992; Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. Journal of General Virology 73:1131–1141
   [Google Scholar]
5. Falk K., Rötzschke O., Takiguchi M., Gnau V., Stevanovic S., Jung G., Rammensee H.-G. 1995; Peptide motifs of HLA-B58, B60, B61, and B62 molecules. Immunogenetics 41:165–168
   [Google Scholar]
6. Jacobson S., Richert J. R., Biddison W. E., Satinsky A., Hartzman R. J., McFarland H. F. 1984; Measles virusspecific T4⁺ human cytotoxic T cell clones are restricted by class II HLA antigens. Journal of Immunology 133:754–757
   [Google Scholar]
7. Jacobson S., Sekaly R. P., Jacobson C., McFarland H. F., Long E. O. 1989; HLA class Il-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. Journal of Virology 63:1756–1762
   [Google Scholar]
8. Jaraquemada D., Marti M., Long E. O. 1990; An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class Il-restricted T cells. Journal of Experimental Medicine 172:947–954
   [Google Scholar]
9. Kita H., Moriyama T., Kaneko T., Harass L., Nomura M., Miura H., Nakamura L., Yazaki Y., Imawari M. 1993; HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039–1044
   [Google Scholar]
10. Kita H., Hiroishi K., Moriyama T., Kaneko T., Ohnishi S., Yazaki Y., Imawari M. 1995; A minimal and optimal cytotoxic T-cell epitope within hepatitis C virus nucleoprotein. Journal of General Virology 76:3189–3193
    [Google Scholar]
11. Koziel M. J., Dudley D., Wong J. T., Dienstag J., Houghton M., Ralston R., Walker B. D. 1992; Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. Journal of Immunology 149:3339–3344
    [Google Scholar]
12. Koziel M. J., Dudley D., Afdhal N., Choo Q. L., Houghton M., Ralston R., Walker B. D. 1993; Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. Journal of Virology 67:7522–7532
    [Google Scholar]
13. Koziel M. J., Dudley D., Afdhal N., Grakoui A., Rice C. M., Choo Q.-L., Houghton M., Walker B. D. 1995; HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. Journal of Clinical Investigation 96:2311–2321
    [Google Scholar]
14. Muller D., Koller B. H., Whitton J. L., LaPan K. E., Brigman K. K., Frelinger J. A. 1992; LCMV-specific, class Il-restricted cytotoxic T cells in /?₂-microglobulin-deficient mice. Science 255:1576–1578
    [Google Scholar]
15. Okamoto H., Sugiyama Y., Okada S., Kurai K., Akahane Y., Sugai Y., Tanaka T., Sato K., Tsuda F., Miyakawa Y., Mayumi M. 1992; Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. Journal of General Virology 73:673–679
    [Google Scholar]
16. Shimizu Y. K., Hijikata M., Iwamoto A., Alter H. J., Purcell R. H., Yoshikura H. 1994; Neutralizing antibodies against hepatitis C virus and the emergence of neutralizing escape mutant viruses. Journal of Virology 68:1494–1500
    [Google Scholar]
17. Shirai M., Okada H., Nishioka M., Akatsuka T., Wychowski C., Houghten R., Pendelton C. D., Feinstone S. M., Berzofsky J. A. 1994; An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. Journal of Virology 68:3334–3342
    [Google Scholar]
18. Weiner A. J., Christopherson C., Hall J. E., Bonino F., Saracco G., Brunetto M. R., Crawford K., Marion C. D., Crawford K. A., Venkatakrishna S., Miyamura T., McHutchinson J., Cuypers T., Houghton M. 1991; Sequence variation in hepatitis C viral isolates. Journal of Hepatology 13 suppiementum 4:S6–S14
    [Google Scholar]
19. Yasukawa M., Zarling J. M. 1984; Human cytotoxic T cell clones directed against herpes simplex virus-infected cells I. Lysis restricted by HLA class II MB and DR antigens. Journal of Immunology 133:422–427
    [Google Scholar]
20. Yasukawa M., Inatsuki A., Kobayashi Y. 1989; Differential in vitro activation of CD4⁺CD8~ and CD8⁺CD4~ herpes simplex virusspecific human cytotoxic T cells. Journal of Immunology 143:2051–2057
    [Google Scholar]